MS 8-K Current Reports

MORGAN STANLEY 8-K Report, Financial Results (Oct 14, 2026)

Morgan Stanley reported third-quarter 2026 results (quarter ended September 30, 2026) with net revenues of $20.3 billion, up 12% year over year, and net income applicable to Morgan Stanley of $4.9 billion, up 6%. Diluted EPS was $3.03 versus $2.80 a year ago, and ROTCE was 22.6% versus 23.5%. Pre-tax income rose 7% to $6.5 billion, though it fell 12% sequentially from a stronger second quarter. Results were driven by Equity trading strength in Institutional Securities and record Wealth Management revenues, while Fixed Income declined 7% year over year and Investment Management revenues fell 12% on a carried interest reversal. The quarter's growth was broad but uneven. Institutional Securities revenues rose 18% to $10.0 billion, led by Equity (up 41%) and Advisory (up 30%), though both sequentially and in some lines the picture was weaker. Wealth Management delivered record revenues of $9.1 billion, a 10% increase, with a 30.4% pre-tax margin and record net new assets of $232 billion, just over half linked to IPO-related flows. Expenses rose 12% year over year, and the provision for credit losses increased to $148 million from zero, reflecting loan growth and $105 million of charge-offs. Capital remained strong, with a Standardized CET1 ratio of 14.9%, though it was flat-to-slightly-down year over year and the leverage-based ratios declined (Tier 1 leverage 5.9% versus 6.8%; SLR 4.8% versus 5.5%) as the balance sheet expanded. The firm repurchased $1.5 billion of stock and declared a $1.15 quarterly dividend. Investors will want to watch the sequential revenue decline, the rising loan book and credit provisions, and the leverage ratio compression as the balance sheet grows.

Oct 14, 2026 8-K

MORGAN STANLEY 8-K Report, Financial Results (Jul 15, 2026)

Morgan Stanley reported second-quarter 2026 results on July 15, 2026 that were record-level on several fronts. Firm net revenues rose 27% year over year to $21.3 billion (up 4% sequentially), net income applicable to Morgan Stanley reached $5.6 billion, and diluted EPS was $3.46 versus $2.13 a year earlier. Return on average tangible common equity was 26.6%, and the expense efficiency ratio improved to 65% from 71%. Pre-tax income of $7.3 billion was up 59% year over year. Growth was broad-based across segments: Institutional Securities revenues rose 44% to a record $11.0 billion, led by Equities (+69%) and Investment Banking (+58%), while Wealth Management revenues rose 14% to a record $8.9 billion, with record net new assets of $148 billion and total client assets of $10 trillion across Wealth and Investment Management. Capital and shareholder returns remained strong, though some metrics moved modestly lower. The Standardized CET1 ratio was 14.8%, down from 15.0% a year ago and 15.1% in the prior quarter, while the Tier 1 leverage ratio and SLR declined to 6.0% and 4.9%. Book value per share rose to $67.80 and tangible book value per share to $53.18. The Board reauthorized a multi-year buyback of up to $20 billion beginning in the third quarter of 2026 and raised the quarterly dividend by 15 cents to $1.15. The company repurchased $1.5 billion of stock in the quarter. Share count fell to 1,572 million from 1,598 million a year earlier. Investors should note several watch items. Provision for credit losses was flat sequentially at $98 million, but non-compensation expenses rose 16% sequentially to $5.7 billion, driven by execution-related costs, marketing, and other expenses. Fixed Income revenues fell 27% sequentially, and Investment Management's Equity net outflows widened. Figures are preliminary, and capital ratios are estimates subject to revision in the Form 10-Q. The 8-K furnishes the earnings release and financial supplement; it does not contain a formal guidance update.

Jul 15, 2026 8-K

MORGAN STANLEY 8-K Report, Corporate Update (Jun 24, 2026)

Morgan Stanley (NYSE: MS) announced on June 24, 2026 that it will raise its quarterly common stock dividend by $0.15, from $1.00 to $1.15 per share, beginning with the dividend expected to be declared in the quarter ending September 30, 2026. The Board also reauthorized a multi-year common equity share repurchase program of up to $20 billion with no set expiration date, starting in the third quarter. Repurchases will be executed from time to time at management's discretion, subject to market conditions, capital position, and economic and earnings outlook. On the regulatory side, the Federal Reserve's 2026 supervisory stress test results do not change Morgan Stanley's Stress Capital Buffer (SCB). The firm remains subject to its current 4.3% SCB requirement until October 1, 2027, when a new SCB may apply based on the 2027 stress test. Together with other elements of the capital framework, this SCB yields an aggregate U.S. Basel III Standardized CET1 ratio of 11.8%, compared with the firm's actual 15.1% CET1 ratio as of March 31, 2026, indicating a substantial capital cushion above requirements. For investors, the announcement signals management confidence in the firm's capital generation and provides a clear, sizable increase in shareholder returns through both a 15% dividend hike and a $20 billion buyback authorization. The CEO framed the move as balancing ongoing investment in growth across the Integrated Firm with greater capital return. Investors should note that the timing and size of buybacks are discretionary and contingent on market and earnings conditions.

Jun 24, 2026 8-K

Shareholder Matters

MORGAN STANLEY 8-K Report, Shareholder Vote Results (May 15, 2026)

Morgan Stanley (MS) filed an 8-K report on May 15, 2026, detailing the outcomes of its 2026 Annual Meeting of Shareholders held on May 14, 2026. The report indicates strong shareholder support for the company's leadership and operational choices. All director nominees were elected, and the appointment of Deloitte & Touche LLP as the independent auditor for the fiscal year 2026 was ratified with overwhelming approval. Furthermore, shareholders approved the compensation of named executive officers on a non-binding advisory basis. However, a shareholder proposal requesting an independent Board Chairman was not approved. This indicates a divergence in shareholder sentiment on corporate governance structure, with the majority preferring the current structure. The substantial turnout and voting results suggest a stable shareholder base generally aligned with the company's current strategic direction and governance.

May 15, 2026 8-K

MORGAN STANLEY 8-K Report, Financial Results (Apr 15, 2026)

Morgan Stanley reported a record first quarter 2026, with net revenues of $20.6 billion (up 16% year over year from $17.7 billion), pre-tax income of $7.0 billion (up 26%), and net income applicable to Morgan Stanley of $5.6 billion. Diluted EPS rose to $3.43 from $2.60, and return on average tangible common equity reached 27.1% versus 23.0% a year earlier. The expense efficiency ratio improved to 65% from 68%, showing operating leverage even as the firm absorbed $178 million of severance costs tied to a March workforce action affecting about 2% of its global workforce. Growth was broad-based. Institutional Securities revenues rose 19% to a record $10.7 billion, led by Equity (up 25% to $5.1 billion, a record) and Fixed Income (up 29% to $3.4 billion), while Investment Banking grew 36% on higher advisory and underwriting activity. Wealth Management delivered record net revenues of $8.5 billion (up 16%) with a 30.4% pre-tax margin, net new assets of $118 billion, and fee-based asset flows of $54 billion. Investment Management was the relative laggard, with revenues down 4% to $1.5 billion and pre-tax income down 13%, and it recorded negative equity flows. Capital and shareholder returns remained strong. The Standardized CET1 ratio was 15.1% (versus 15.3% a year ago), the firm repurchased $1.75 billion of common stock, and the Board declared a $1.00 quarterly dividend payable May 15, 2026. Balance sheet growth was notable, with total assets up 22% year over year to $1.58 trillion and loans up 18%. The Tier 1 leverage and SLR ratios declined year over year, reflecting the larger balance sheet, and the effective tax rate fell to 19.6% from 21.2%, partly helped by share-based payment benefits. Investors should note that the quarter included methodology changes, including the discontinuation of non-GAAP DCP adjustments and a restatement of Investment Management flows and AUM classifications that excluded distributions.

Apr 15, 2026 8-K

MORGAN STANLEY 8-K Report, Corporate Update (Feb 11, 2026)

Morgan Stanley (MS) announced the 2025 compensation for its CEO, Edward Pick, reflecting his performance and the firm's strong financial results during his tenure. The Compensation Committee cited exceptional performance, evidenced by record revenues and net income, alongside the consistent execution of the firm's capital management strategy. Mr. Pick's total compensation for 2025 was set at $45 million, with a significant portion structured as performance-vested equity to align executive interests with shareholder value. These strong 2025 results include record net revenues of $70.6 billion, up 14% year-over-year, and net income of approximately $16.9 billion. Key financial metrics such as pre-tax profit, ROTCE, and Common Equity Tier 1 Capital Ratio all showed robust improvement. Furthermore, the firm demonstrated a commitment to shareholder returns through increased dividends and significant total shareholder returns of 45%, alongside a market capitalization reaching $282 billion.

Feb 11, 2026 8-K

MORGAN STANLEY 8-K Report, Financial Results (Jan 15, 2026)

Morgan Stanley reported strong fourth-quarter and full-year 2025 results on January 15, 2026. Fourth-quarter net revenues were $17.9 billion, up 10% year over year, and diluted EPS was $2.68 versus $2.22 a year ago. Full-year net revenues reached a record $70.6 billion (up 14%), net income applicable to Morgan Stanley was $16.9 billion, diluted EPS was $10.21 (up 28%), and ROTCE was 21.6% versus 18.8% in 2024. Sequentially, fourth-quarter revenue fell 2% from $18.2 billion in the third quarter, with Institutional Securities down 7% on lower Fixed Income and Equity trading versus a strong prior quarter, while Investment Banking rose 14%. The segment picture was mixed but broadly constructive. Wealth Management delivered record full-year net revenues of $31.8 billion and a 29.3% full-year pre-tax margin, with $356 billion in net new assets and total client assets of $9.3 trillion. Institutional Securities posted record full-year revenues of $33.1 billion, led by Equity (up 28%) and Investment Banking (up 23%). Investment Management reached record revenues of $6.5 billion. Fourth-quarter provision for credit losses was modest at $18 million, though Institutional Securities took $87 million of charge-offs tied largely to a single commercial real estate loan. Capital and shareholder returns remained strong. The Standardized CET1 ratio was an estimated 15.0% at year end, versus 15.9% a year earlier, and the firm repurchased $4.6 billion of stock in 2025 and $1.5 billion in the fourth quarter. The Board declared a $1.00 quarterly dividend payable February 13, 2026. The investor presentation reaffirmed firmwide goals of more than $10 trillion in client assets, a 30% Wealth Management pre-tax margin, 20% ROTCE, and a 70% efficiency ratio. Investors should note the sharp year-over-year gain in full-year profitability alongside a lower year-end CET1 ratio and a meaningful increase in total assets to $1.42 trillion.

Jan 15, 2026 8-K

MORGAN STANLEY 8-K Report, Financial Results (Oct 15, 2025)

Morgan Stanley reported third-quarter 2025 results on October 15, 2025 that were strong across the board. Net revenues reached a record $18.2 billion, up 18% year over year from $15.4 billion, and net income applicable to Morgan Stanley rose 45% to $4.6 billion. Diluted EPS was $2.80 versus $1.88 a year ago, and return on average tangible common equity (ROTCE) expanded to 23.5% from 17.5%. Provision for credit losses was zero, compared with $79 million a year earlier, and the expense efficiency ratio improved to 67% from 72%, reflecting operating leverage as revenue growth outpaced expense growth. Growth was broad-based. Institutional Securities revenue rose 25% to $8.5 billion, led by Equity (up 35%) and a rebound in Investment Banking (up 44%), with record prime brokerage results. Wealth Management revenue grew 13% to $8.2 billion with a 30.3% pre-tax margin, $81 billion of net new assets, and fee-based client assets of $2.65 trillion. Investment Management revenue rose 13% to $1.7 billion, and AUM reached $1.8 trillion with $16.5 billion of long-term net inflows. Capital remained strong, with a Standardized CET1 ratio of 15.2%, and the Federal Reserve lowered the firm's Stress Capital Buffer from 5.1% to 4.3% effective October 1, 2025, bringing the aggregate U.S. Basel III Standardized CET1 requirement to 11.8%. Capital return remained active: the firm repurchased $1.1 billion of common stock in the quarter and declared a $1.00 quarterly dividend payable November 14, 2025 to holders of record on October 31, 2025. The results were reported under U.S. GAAP, with non-GAAP adjustments excluding mark-to-market effects on deferred cash-based compensation plans presented as supplemental measures.

Oct 15, 2025 8-K

MORGAN STANLEY 8-K Report, Corporate Update (Sep 30, 2025)

Morgan Stanley (NYSE: MS) disclosed in an 8-K dated September 30, 2025 that the Federal Reserve reduced its Stress Capital Buffer (SCB) from 5.1% to 4.3%, effective October 1, 2025. The change followed the Company's request for reconsideration of the preliminary SCB the Fed announced in June 2025. Together with other elements of the regulatory capital framework, the revised SCB produces an aggregate U.S. Basel III Standardized Approach Common Equity Tier 1 (CET1) ratio of 11.8%, compared with 15.0% as of June 30, 2025. For investors, the key point is that the lower SCB reduces the regulatory capital Morgan Stanley must hold above the minimum. This gives the firm more flexibility for capital returns such as dividends and share repurchases, and for balance sheet deployment in its core businesses. The filing does not state how much of the 15.0% to 11.8% change is attributable to the SCB alone versus other framework components, so the two ratios should be compared with care. The 8-K itself does not provide a new earnings figure or guidance. Management's statement, issued by CFO Sharon Yeshaya, thanked the Fed for its reconsideration and emphasized continued engagement on the stress testing framework. It also stated that the firm intends to support global client activity, invest in core businesses, and consistently grow its quarterly dividend. These are management intentions rather than committed actions, and the forward-looking statement disclaimers in the release apply.

Sep 30, 2025 8-K

MORGAN STANLEY 8-K Report, Corporate Update (Sep 23, 2025)

Morgan Stanley (MS) has filed an 8-K report to disclose the approval of the forms of Master Notes for its Global Medium-Term Notes programs. This filing pertains to the upcoming offerings of certain debt securities under Series I for the parent company and Series A for its subsidiary, Morgan Stanley Finance LLC. These approved master note forms are a procedural step that allows the company to issue new debt under existing indenture agreements. Investors should note that this is a standardized update related to debt issuance infrastructure and not an indication of new debt issuance in this specific report.

Sep 23, 2025 8-K

MORGAN STANLEY 8-K Report, Financial Results (Jul 16, 2025)

Morgan Stanley reported second-quarter 2025 results on July 16, 2025, with net revenues of $16.8 billion (up 12% year over year from $15.0 billion), net income applicable to Morgan Stanley of $3.5 billion, and diluted EPS of $2.13 versus $1.82 a year earlier. Return on tangible common equity was 18.2% for the quarter and 20.6% for the first half, and book value per share rose to $61.59. Growth was broad-based: Wealth Management revenue rose 14% to $7.8 billion on asset management fees, transactional activity, and net interest income, while Institutional Securities revenue grew 9% to $7.6 billion, led by Equity (up 23%) and Fixed Income (up 9%). Investment Banking revenue fell 5%, with advisory down on fewer completed M&A deals. Quarter-over-quarter, net revenues declined 5% from $17.7 billion, largely because Institutional Securities fell 15% after an unusually strong first quarter, and pre-tax income dropped 17% to $4.6 billion. Expenses rose 10% year over year, and provision for credit losses increased to $196 million from $76 million, driven by corporate loan growth and a modestly weaker macro outlook. Management reported a 71% expense efficiency ratio for the quarter, and the Standardized CET1 ratio was 15.0%, versus 15.2% a year earlier. Capital return remained a key theme. The company repurchased $1.0 billion of stock in the quarter, the Board reauthorized a multi-year buyback of up to $20 billion starting in Q3 2025, and the quarterly dividend was increased 7.5 cents to $1.00 per share. Investors should note that results are shaped by mark-to-market swings in deferred cash-based compensation plans (DCP), so adjusted figures (excluding DCP) show slightly lower net revenues of $16.4 billion.

Jul 16, 2025 8-K

Leadership ChangesExhibits & Filings

MORGAN STANLEY 8-K Report, Corporate Update (Jul 1, 2025)

Morgan Stanley (NYSE: MS) announced on July 1, 2025 a capital return package following the Federal Reserve's 2025 CCAR stress test results. The quarterly common stock dividend will rise 7.5 cents, from $0.925 to $1.00 per share, beginning with the dividend expected to be declared in the third quarter of 2025. The Board also reauthorized a multi-year common equity share repurchase program of up to $20 billion with no set expiration date, starting in the third quarter of 2025. Repurchases will be executed opportunistically based on market conditions, capital position, and the economic and earnings outlook. The key regulatory input is the Stress Capital Buffer (SCB), which the Fed's June 27, 2025 results set at 5.1% for October 1, 2025 through September 30, 2026. Combined with other elements of the regulatory capital framework, this yields an aggregate U.S. Basel III Standardized Approach CET1 ratio requirement of 12.6%, compared with the firm's actual CET1 ratio of 15.3% as of March 31, 2025. That implies roughly 270 basis points of headroom above the requirement, which underpins the capacity for the higher dividend and buyback. The company characterized the stress test outcome as an improvement, and CEO Ted Pick tied it to the franchise's scale, global reach, and durable returns. Investors should note that the Federal Reserve has proposed a rulemaking that could change how SCBs are calculated for large bank holding companies. If adopted, it could alter Morgan Stanley's SCB and the capital distribution capacity implied by these announcements, and the company has committed to update investors if that occurs. The buyback is described as flexible rather than a fixed commitment, so the actual pace of repurchases will depend on future market and earnings conditions.

Jul 1, 2025 8-K

MORGAN STANLEY 8-K Report, Executive Changes (Jun 16, 2025)

Morgan Stanley (NYSE: MS) filed a Form 8-K on June 16, 2025 to report that its Board of Directors elected Lynn J. Good to the Board, effective July 18, 2025. Ms. Good is the former Chair, CEO and President of Duke Energy Corporation and has an accounting and audit background, including prior roles as an audit partner at Deloitte & Touche and Arthur Andersen. The Board determined she is independent under the Company's director independence standards, and she will join the Audit Committee upon her election. The filing is a governance event rather than a financial one; it contains no earnings, revenue, capital, or guidance information. The appointment expands the Board to 15 members, according to the accompanying press release (Exhibit 99.1). Her compensation will follow the non-employee director program described in the company's April 4, 2025 proxy statement, so the filing does not introduce a new pay package or disclosed dollar amounts. Chairman and CEO Ted Pick and Governance and Sustainability Committee Chair Ray Wilkins both praised her finance and management experience. For investors, the main takeaways are the strengthening of the Audit Committee's financial reporting expertise and the continuity of board governance practices. The event carries no immediate financial impact, but it reflects the Board's ongoing refresh and oversight priorities. Ms. Good's additional outside role on the Boeing board is disclosed in the press release and should be considered alongside her existing commitments.

Jun 16, 2025 8-K

Leadership ChangesShareholder MattersExhibits & Filings

MORGAN STANLEY 8-K Report, Executive Changes (May 16, 2025)

Morgan Stanley filed an 8-K on May 16, 2025, reporting on key outcomes from its Annual Meeting of Shareholders held on May 15, 2025. The primary focus of the filing is the shareholder approval of the amended and restated Equity Incentive Compensation Plan (EICP). This plan amendment will provide an additional 50 million shares for grants and extend the plan's term by three years, signaling a continued commitment to incentivizing employees and executives through equity. Additionally, shareholders overwhelmingly ratified the appointment of Deloitte & Touche LLP as the independent auditor for fiscal year 2025 and approved the compensation of named executive officers through a non-binding advisory vote. Other significant outcomes from the meeting include the election of all director nominees to the Board of Directors. However, a shareholder proposal requesting annual disclosure of the Company’s Energy Supply Ratio was not approved. The filing provides detailed vote counts for each proposal, confirming broad shareholder support for the company's governance and executive compensation structure, with the exception of the environmental disclosure proposal.

May 16, 2025 8-K

MORGAN STANLEY 8-K Report, Financial Results (Apr 11, 2025)

Morgan Stanley reported first-quarter 2025 results on April 11, 2025, with net revenues of a record $17.7 billion, up 17% from $15.1 billion a year earlier, and EPS of $2.60 versus $2.02. Net income applicable to Morgan Stanley rose 26% to $4.3 billion, pre-tax income climbed 26% to $5.5 billion, and ROTCE expanded to 23.0% from 19.7%. The expense efficiency ratio improved to 68% from 71%, despite a $144 million severance charge tied to a March reduction in force affecting roughly 2% of the global workforce. The quarter's strength was led by Institutional Securities, which posted record net revenues of $9.0 billion, up 28% year over year, driven by a record $4.1 billion in Equity revenues (up 45%) and a 5% rise in Fixed Income. Wealth Management generated $7.3 billion in net revenues (up 6%) with a 26.6% pre-tax margin and $94 billion in net new assets, while Investment Management grew revenues 16% to $1.6 billion. Fee-based client assets reached $2.35 trillion and total client assets $7.7 trillion according to management's release, though the financial supplement reports total client assets of $6.0 trillion for Wealth Management, a figure that should be reconciled against the release's broader $7.7 trillion firm-wide measure. On capital and shareholder returns, the Standardized CET1 ratio was 15.3%, up from 15.0% a year earlier but down from 15.9% at year-end 2024, reflecting higher risk-weighted assets. Morgan Stanley repurchased $1.0 billion of common stock and declared a quarterly dividend of $0.925 per share payable May 15, 2025. Provision for credit losses rose to $135 million from a net release a year earlier, driven by growth in secured lending and corporate loans and a weaker macroeconomic forecast, which investors may want to monitor as lending balances expand.

Apr 11, 2025 8-K

MORGAN STANLEY 8-K Report, Corporate Update (Apr 1, 2025)

Morgan Stanley's Board of Directors has nominated Douglas L. Peterson, former CEO of S&P Global Inc., for election to the Board at the upcoming annual shareholder meeting on May 15, 2025. Mr. Peterson brings extensive experience in the financial services industry, spanning 40 years, and is expected to provide valuable insights with his international and financial markets perspective. The nomination signifies a move to strengthen the Board's expertise, particularly in areas critical to a global financial institution like Morgan Stanley. His designation as independent, as determined by the Company's Corporate Governance Policies, further underscores the Board's commitment to robust governance. Upon shareholder approval, Mr. Peterson will also serve on the Risk Committee, enhancing the Board's oversight capabilities in a key area of financial services.

Apr 1, 2025 8-K

Leadership Changes

MORGAN STANLEY 8-K Report, Executive Changes (Mar 28, 2025)

Morgan Stanley has announced a key executive change, with Raja Akram tendering his resignation from his roles as Deputy Chief Financial Officer, Chief Accounting Officer, and Controller. This departure is effective after the completion of his required notice period, indicating a planned transition rather than an immediate exit. While Mr. Akram's resignation is a significant development within the finance department, the company states he is leaving to pursue another opportunity. Investors should monitor the company's subsequent filings for details on the appointment of his successor and any potential impact on financial reporting and oversight. The exact timeline for his departure and the interim arrangements will be crucial information to track.

Mar 28, 2025 8-K

MORGAN STANLEY 8-K Report, Corporate Update (Feb 13, 2025)

Morgan Stanley (MS) has filed an 8-K to announce the 2024 compensation for its Chief Executive Officer, Edward Pick. The Compensation Committee of the Board of Directors, in consultation with the full Board, determined Mr. Pick's compensation based on his strong leadership and the firm's exceptional financial performance in 2024. This includes record net revenues of $61.8 billion, a significant increase in pre-tax profit, and robust earnings per share. Mr. Pick's total compensation for 2024 has been set at $34 million. A substantial portion of this compensation is structured to align with shareholder interests, with 75% of his bonus deferred over three years and delivered through equity awards, 100% of which are subject to cancellation. Furthermore, 60% of his bonus is performance-vested equity, underscoring the link between executive pay and the firm's sustained success and shareholder returns, which saw a market cap exceeding $200 billion and a 40% total shareholder return.

Feb 13, 2025 8-K

Leadership ChangesExhibits & Filings

MORGAN STANLEY 8-K Report, Financial Results (Jan 16, 2025)

Morgan Stanley reported strong fourth-quarter and full-year 2024 results on January 16, 2025. Fourth-quarter net revenues rose 26% year over year to $16.2 billion, and diluted EPS was $2.22, up from $0.85. Full-year net revenues reached a record $61.8 billion, up 14%, with net income applicable to Morgan Stanley of $13.4 billion and diluted EPS of $7.95 versus $5.18 in 2023. Full-year ROTCE was 18.8% and the expense efficiency ratio improved to 71% from 77%, reflecting both revenue strength and expense discipline. Results were broad-based: Institutional Securities net revenues rose 22% for the year to $28.1 billion, with Investment Banking up 35% and Equities a record, while Wealth Management grew 8% to $28.4 billion and Investment Management grew 9% to $5.9 billion. Capital and shareholder returns remained strong. The Standardized CET1 ratio was 15.9% at year-end after accreting $5.6 billion of CET1 capital, and the firm repurchased $3.3 billion of stock during 2024. The Board declared a quarterly dividend of $0.925 per share, payable February 14, 2025. Wealth Management client assets reached $7.9 trillion across Wealth and Investment Management, and fee-based flows totaled $123 billion for the year. The accompanying investor presentation frames management's Four Pillars strategy (strategy, culture, financial strength, growth) and sets firmwide goals of a 20% ROTCE, a 70% efficiency ratio, a Wealth Management pre-tax margin of 30%, and over $10 trillion in client assets. Investors should note that some results were helped by market conditions and mark-to-market effects, that provisions for credit losses rose in the fourth quarter, and that the presentation contains forward-looking targets subject to market and regulatory risks.

Jan 16, 2025 8-K

MORGAN STANLEY 8-K Report, Executive Changes (Dec 20, 2024)

Morgan Stanley (MS) filed an 8-K report on December 20, 2024, announcing a change in its Board of Directors. Stephen Luczo has resigned from the Board, effective December 31, 2024, citing personal reasons and confirming no disagreement with the company's operations or policies. This resignation, coupled with the previously announced retirement of Mr. Gorman, will lead to a reduction in the Board's size from 15 to 13 directors, effective January 1, 2025. The filing also includes standard disclosures regarding interactive data files in XBRL format.

Dec 20, 2024 8-K

Leadership ChangesOther EventsExhibits & Filings

MORGAN STANLEY 8-K Report, Executive Changes (Oct 24, 2024)

Morgan Stanley (NYSE: MS) disclosed in an 8-K filed October 24, 2024 that CEO Ted Pick has been elected by the Board to also serve as Chairman of the Board of Directors, effective January 1, 2025. The change consolidates the Chairman and CEO roles under Pick, who succeeds James P. Gorman as Chairman. Gorman steps down as Chairman and leaves the Board at the end of 2024, retires from employment at the firm, and will be named Chairman Emeritus, a non-director honorary title. The filing also discloses a post-retirement advisory arrangement with Gorman running from January 1, 2025 through the end of 2026. He will advise on matters where the firm wants to draw on his 14 years as CEO. Compensation includes an annual fee of $400,000, continued health benefits, a car and driver, office and administrative support, and indemnification and advancement rights as an advisor under the Bylaws. The Board may terminate the arrangement at any time or choose not to renew it. The amounts are modest relative to the firm's scale, and the arrangement is structured as a discretionary, time-limited consulting role rather than a board or executive seat. For investors, the event is largely a planned leadership transition rather than a change in strategy or financial condition. The filing contains no financial results or guidance. The key governance points are the combined Chairman/CEO structure, which concentrates authority in one executive, and the Lead Director role held by Tom Glocer, which serves as the main check on that concentration. Investors may want to watch how the Board structures oversight under a combined role.

Oct 24, 2024 8-K

Shareholder MattersCorporate ChangesOther Events+1

MORGAN STANLEY 8-K Report, Financial Results (Oct 16, 2024)

Morgan Stanley reported third-quarter 2024 results (quarter ended September 30, 2024) that were strong across all three business segments. Net revenues rose 16% year-over-year to $15.4 billion, net income applicable to Morgan Stanley increased 32% to $3.2 billion, and diluted EPS was $1.88 versus $1.38 a year earlier. Return on tangible common equity (ROTCE) was 17.5% for the quarter and 18.2% year-to-date, and the expense efficiency ratio improved to 72% from 75%. Revenue growth was broad-based: Investment Banking rose 56%, Equity rose 21%, and Wealth Management hit record net revenues of $7.3 billion. Pre-tax income of $4.2 billion was up 34%. Capital generation remained robust. The Firm accreted $2.1 billion of CET1 capital, ending the quarter with a Standardized CET1 ratio of 15.1%, down modestly from 15.6% a year earlier but up from 15.2% in the prior quarter. Management repurchased $0.8 billion of common stock and declared a quarterly dividend of $0.925 per share, payable November 15, 2024. Book value per share rose to $58.25 and tangible book value per share to $43.76, both up year-over-year. Investors should note that part of the revenue and compensation swing reflects mark-to-market movements on deferred cash-based compensation (DCP) investments, which were a $239 million benefit to net revenues this quarter. Excluding DCP, net revenues were $15.1 billion, still up about 12% from the prior year. Net interest income declined 9% year-over-year in Wealth Management due to lower sweep deposit balances, a key watch item for earnings sensitivity. Client assets grew to nearly $6 trillion and fee-based assets to $2.3 trillion, supporting recurring asset management revenue.

Oct 16, 2024 8-K

MORGAN STANLEY 8-K Report, Rights Modification (Jul 30, 2024)

Morgan Stanley (MS) has filed an 8-K report detailing the establishment and terms of its 6.625% Non-Cumulative Preferred Stock, Series Q. This new series of preferred stock, with a liquidation preference of $25,000 per share, was officially designated on July 29, 2024, and its issuance on July 30, 2024, introduces specific restrictions. Investors should note that the issuance of this Series Q Preferred Stock imposes limitations on Morgan Stanley's ability to declare or pay dividends on, or repurchase, its "junior stock," which includes common stock. These restrictions are triggered if the company fails to declare and pay full dividends on the Series Q Preferred Stock. This filing also references related exhibits concerning the depositary shares representing interests in this new preferred stock offering.

Jul 30, 2024 8-K

MORGAN STANLEY 8-K Report, Financial Results (Jul 16, 2024)

Morgan Stanley reported second-quarter 2024 results (quarter ended June 30, 2024) with net revenues of $15.0 billion, up 12% from $13.5 billion a year earlier, and diluted EPS of $1.82 versus $1.24. Net income applicable to Morgan Stanley was $3.1 billion, up 41% year over year, and return on tangible common equity (ROTCE) was 17.5% versus 12.1%. Results were driven by a strong Institutional Securities segment, where net revenues rose 23% to $7.0 billion on higher Investment Banking (up 51%), Equity (up 18%), and Fixed Income (up 16%) revenues. Wealth Management was broadly flat-to-up at $6.8 billion, supported by record asset management revenues, while Investment Management grew 8% to $1.4 billion. Profitability improved meaningfully: the firm's expense efficiency ratio fell to 72% from 78%, and pre-tax income rose 45% to $4.1 billion. Provision for credit losses dropped to $76 million from $161 million. Capital remained strong, with a standardized CET1 ratio of 15.2% (versus 15.5% a year ago), and the firm accreted $1.5 billion of CET1 capital during the quarter. Management also raised the quarterly dividend to $0.925 per share from $0.85 and reauthorized a multi-year buyback of up to $20 billion, while repurchasing $0.8 billion of stock during the quarter. For investors, the key points are the sharp recovery in investment banking and trading activity, improving operating leverage, and continued capital return. Watch-points include a decline in Wealth Management net interest income (down 17% year over year) as clients redeploy cash, a 9% sequential rise in non-compensation expenses, and sequentially lower net revenues versus the first quarter of 2024.

Jul 16, 2024 8-K

Leadership ChangesShareholder Matters

MORGAN STANLEY 8-K Report, Corporate Update (Jun 28, 2024)

Morgan Stanley (NYSE: MS) announced on June 28, 2024 that it will raise its quarterly common stock dividend to $0.925 per share from $0.85, a 7.5-cent (about 8.8%) increase. The higher rate applies beginning with the dividend expected to be declared by the Board in the third quarter of 2024. At the current quarterly rate, the new dividend implies annualized payments of $3.70 per share, versus $3.40 previously. CEO Ted Pick noted this is the third consecutive year of a 7.5-cent increase. The Board also reauthorized a multi-year common equity share repurchase program of up to $20 billion, with no set expiration date, beginning in the third quarter of 2024. Repurchases will be made from time to time at prices management considers appropriate, depending on market conditions, the firm's capital position, and its economic and earnings outlook. The filing does not commit to a specific repurchase pace. The capital actions follow the Federal Reserve's publication of 2024 Comprehensive Capital Analysis and Review (CCAR) results on June 26, 2024. Morgan Stanley expects a Stress Capital Buffer (SCB) of 6.0% effective October 1, 2024 through September 30, 2025. Together with other framework features, this yields an aggregate U.S. Basel III Standardized Approach CET1 requirement of 13.5%, compared with the firm's reported CET1 ratio of 15.0% as of March 31, 2024. That cushion above the requirement supports the increased dividend and buyback capacity.

Jun 28, 2024 8-K

MORGAN STANLEY 8-K Report, Executive Changes (May 24, 2024)

Morgan Stanley has filed an 8-K report detailing significant executive changes and the outcomes of its 2024 Annual Meeting of Shareholders. Notably, James P. Gorman will step down as Executive Chairman and a Board member effective December 31, 2024. This transition marks the end of an era for a long-standing leader at the financial services giant. The report also provides results from the shareholder meeting, where all director nominees were elected and Deloitte & Touche LLP was ratified as the independent auditor for the upcoming fiscal year. Shareholder approval was also given for executive compensation (on an advisory basis) and the Non-U.S. Nonqualified Employee Stock Purchase Plan.

May 24, 2024 8-K

Earnings & Results

MORGAN STANLEY 8-K Report, Financial Results (Apr 16, 2024)

Morgan Stanley reported first-quarter 2024 results on April 16, 2024, with net revenues of $15.1 billion (up 4% year over year from $14.5 billion), net income applicable to Morgan Stanley of $3.4 billion, and diluted EPS of $2.02 versus $1.70 a year earlier. Return on average tangible common equity was 19.7% compared with 16.9% in the prior-year quarter, and the firm's expense efficiency ratio improved to 71% from 72%. Pre-tax income rose 17% to $4.4 billion, helped by a negative provision for credit losses of $6 million, compared with a $234 million provision a year earlier. Growth was broad-based: Institutional Securities revenues rose 3% on strong Equity and underwriting results, Wealth Management revenues rose 5% on record asset management revenues and $95 billion of net new assets, and Investment Management revenues rose 7% on higher average AUM. Several items temper the picture. Fixed Income revenues fell 4% year over year on weaker macro and credit client activity, and Advisory revenues declined 28% on fewer completed M&A deals. Net interest income fell 23% to $1.8 billion as deposit mix shifted, and Wealth Management non-compensation costs included an incremental $42 million FDIC special assessment. The effective tax rate rose to 21.2% from 19.3%, and the tax benefit from employee share-based payments was smaller than a year earlier. Capital remained solid, with a standardized CET1 ratio of 15.1% (flat year over year) and a supplementary leverage ratio of 5.4%, down from 5.5%. Capital returns continued: the firm repurchased $1.0 billion of common stock during the quarter (down from $1.5 billion a year earlier) and declared a quarterly dividend of $0.85 per share, payable May 15, 2024. Book value per share rose to $55.60 and tangible book value per share to $41.07. Overall, the quarter reflects solid execution across the Integrated Firm model, with the main investor watch points being the Advisory slowdown, Fixed Income softness, and the sustainability of record asset management revenues.

Apr 16, 2024 8-K

Leadership ChangesOther Events

MORGAN STANLEY 8-K Report, Executive Changes (Jan 19, 2024)

Morgan Stanley filed an 8-K report on January 19, 2024, detailing the 2023 compensation for its former CEO and now Executive Chairman, James P. Gorman. The Compensation Committee determined Mr. Gorman's 2023 compensation at $37 million, acknowledging his outstanding performance, particularly in executing CEO succession, transitioning leadership, and resolving legal/regulatory matters. This compensation reflects a target range set at the beginning of the year, with a strong performance outcome. A significant portion of his bonus is deferred and equity-based, aligning his interests with shareholders over a three-year period. The report also highlights Morgan Stanley's strong 2023 performance under Mr. Gorman's leadership, including a 14% total shareholder return, $54.1 billion in net revenues, and $9.1 billion in net income. The shift towards Wealth and Investment Management contributing over 60% of pre-tax profit underscores a more balanced business model. Furthermore, the firm announced an increase in the base salary for the new CEO, Ted Pick, to $1.5 million, aligning it with Mr. Gorman's former CEO base salary.

Jan 19, 2024 8-K

Corporate ChangesExhibits & Filings

MORGAN STANLEY 8-K Report, Financial Results (Jan 16, 2024)

Morgan Stanley's fourth quarter and full-year 2023 results, released January 16, 2024, show a firm that remained profitable but with sharply lower earnings versus 2022. Q4 2023 net revenues were $12.9 billion (up about 1% from $12.7 billion a year earlier), while net income applicable to Morgan Stanley fell to $1.5 billion, or $0.85 per diluted share, from $2.2 billion, or $1.26. The quarter absorbed $535 million of pre-tax charges ($0.28 per share), including a $286 million FDIC special assessment and a $249 million legal charge. Full-year net revenues were $54.1 billion (up about 1%), but net income fell to $9.1 billion ($5.18 per share) from $11.0 billion ($6.15 per share). Full-year ROTCE declined to 12.8% from 15.3%, and the expense efficiency ratio rose to 77% from 73%. Segment performance was mixed. Institutional Securities full-year revenue fell 5% to $23.1 billion, with Investment Banking down 13% and Fixed Income down 15%. Wealth Management was the bright spot, with full-year revenue up 8% to $26.3 billion, net new assets of $282 billion, and fee-based client assets reaching $1.98 trillion. Investment Management revenue was flat at $5.4 billion, with AUM rising to $1.46 trillion, though long-term net outflows continued at $15.2 billion for the year. Capital remained strong, with a Standardized CET1 ratio of 15.2%, and the firm repurchased $5.3 billion of common stock during 2023 and declared a $0.85 quarterly dividend. For investors, the key takeaways are that core franchise revenues held up, Wealth Management growth is offsetting weakness in trading and underwriting, and the earnings decline is driven largely by higher expenses and one-time items. Management also presented long-term firmwide goals of a 70% efficiency ratio, 20% ROTCE, over $10 trillion in client assets, and a 30% Wealth Management pre-tax margin, which investors will likely track against future results.

Jan 16, 2024 8-K

MORGAN STANLEY 8-K Report, Bylaw Amendment (Dec 8, 2023)

Morgan Stanley (MS) filed an 8-K on December 8, 2023, to report an amendment to its Amended and Restated Bylaws, effective December 7, 2023. The primary change establishes exclusive forum provisions for certain legal actions against the company. Specifically, the Court of Chancery of the State of Delaware (or federal courts in Delaware if the former lacks jurisdiction) will be the exclusive venue for internal corporate claims. Furthermore, the Bylaws now designate federal district courts of the United States as the exclusive forum for litigation involving claims under the Securities Act of 1933. These provisions aim to streamline and centralize potential litigation, providing greater certainty for both the company and its shareholders regarding where legal disputes will be resolved.

Dec 8, 2023 8-K

Leadership Changes

MORGAN STANLEY 8-K Report, Executive Changes (Dec 1, 2023)

This 8-K filing from Morgan Stanley (MS) reports the unfortunate passing of Mr. Alistair Darling, a member of the company's Board of Directors, on November 30, 2023. Mr. Darling had served on the Board since 2016 and was an active participant in both the Audit Committee and the Risk Committee. His death represents a loss to the Board and the company's governance structure. While the primary focus of this filing is a somber event, investors should note that the company has promptly disclosed this change in its Board composition. The loss of a director, particularly one involved in key committees like Audit and Risk, can sometimes lead to short-term adjustments in board dynamics. However, Morgan Stanley's established governance framework is expected to manage this transition effectively.

Dec 1, 2023 8-K

Leadership ChangesExhibits & Filings

MORGAN STANLEY 8-K Report, Executive Changes (Oct 27, 2023)

Morgan Stanley's October 27, 2023 8-K discloses a planned CEO transition. Board-selected Co-President Edward (Ted) Pick will become Chief Executive Officer effective January 1, 2024, succeeding James P. Gorman, who will become Executive Chairman. Pick, 54, joins the Board as an employee director on the same date, increasing its size from 14 to 15. The Board describes the decision as the outcome of a multi-year succession process, and Gorman has led the firm for 14 years. The filing presents this as an orderly, planned handover rather than a response to performance problems, though the filing itself does not discuss financial results or strategy changes. To support continuity, Andy Saperstein becomes Head of Wealth and Investment Management and Dan Simkowitz becomes Co-President and Head of Institutional Securities, both effective January 1, 2024. Saperstein's role will be Co-President and head of Wealth and Investment Management, while Simkowitz will take on the Institutional Securities leadership that Pick currently holds. Investors should watch how this leadership structure performs, particularly in the Institutional Securities and Wealth Management segments, which are central to the firm's earnings mix. The Compensation Committee approved a one-time equity staking award to each of the three executives, with a grant-date fair value of $20 million each. Each award is 60% performance stock units tied to 2024–2026 ROTCE performance and 40% restricted stock units vesting January 25, 2027. The awards carry clawback and ownership provisions and are described as non-recurring. For shareholders, the key question is whether the retention package aligns the new leadership team with long-term returns, and the executive transition is a key development to monitor.

Oct 27, 2023 8-K

MORGAN STANLEY 8-K Report, Financial Results (Oct 18, 2023)

Morgan Stanley reported third-quarter 2023 results on October 18, 2023, with net revenues of $13.3 billion (up 2% year over year from $13.0 billion), net income applicable to Morgan Stanley of $2.4 billion, and diluted EPS of $1.38 versus $1.47 a year earlier. Return on average tangible common equity was 13.5%, down from 14.6%, and the expense efficiency ratio rose to 75% from 74%. Pre-tax income fell to $3.1 billion from $3.4 billion as compensation and non-compensation expenses both grew. Quarterly revenue was roughly flat sequentially, and the year-over-year earnings decline reflects weaker Investment Banking and Fixed Income activity, higher provisions for credit losses tied to commercial real estate, and higher expenses. The business mix was uneven. Wealth Management was the bright spot, with net revenues of $6.4 billion (up 5%), a 26.7% pre-tax margin, and $22.5 billion of fee-based asset inflows, although net new assets slowed to $35.7 billion from $64.8 billion. Investment Management revenue rose 14% to $1.3 billion, helped by higher carried interest and private fund marks, and long-term net outflows were $6.8 billion. Institutional Securities revenue slipped to $5.7 billion, with Investment Banking down 27% on fewer completed M&A deals, while Equity rose 2% and Fixed Income fell 11%. Capital and shareholder returns remained strong. The standardized CET1 ratio was 15.5%, about 260 basis points above the new aggregate requirement effective October 1, 2023. Morgan Stanley repurchased $1.5 billion of stock during the quarter and declared a $0.85 quarterly dividend. The company also completed the integration of E*TRADE, and management highlighted it as a driver of future revenue synergies.

Oct 18, 2023 8-K

MORGAN STANLEY 8-K Report, Financial Results (Jul 18, 2023)

Morgan Stanley reported second-quarter 2023 results on July 18, 2023, with net revenues of $13.5 billion (versus $13.1 billion a year earlier), net income applicable to Morgan Stanley of $2.2 billion, and diluted EPS of $1.24 (down from $1.39). Profitability weakened year over year: pre-tax income fell to $2.8 billion from $3.3 billion, ROTCE declined to 12.1% from 13.8%, and the firm expense efficiency ratio rose to 78% from 74%. The results were weighed down by $308 million in severance costs tied to an employee action and $99 million in integration-related expenses, which together pressured compensation and non-compensation lines. Segment performance was mixed. Wealth Management delivered record net revenues of $6.7 billion, a 16% increase, with net new assets of roughly $90 billion and a 25.2% pre-tax margin, supported by higher net interest income. Institutional Securities revenue fell to $5.7 billion from $6.1 billion, with Equity down 14% and Fixed Income down 31% on lower client activity and volatility, while Investment Banking was flat. Investment Management revenue declined 9% to $1.3 billion, though long-term net flows turned positive at $1.1 billion. Provisions for credit losses rose to $161 million, driven by commercial real estate credit deterioration. Capital and shareholder returns remained strong. The standardized CET1 ratio was 15.5%, well above requirements, and the firm repurchased $1 billion of stock in the quarter while reauthorizing a multi-year buyback of up to $20 billion. The quarterly dividend was raised 7.5 cents to $0.85 per share. Investors will likely focus on whether Institutional Securities can recover from weaker trading and advisory activity and whether credit pressure in commercial real estate broadens.

Jul 18, 2023 8-K

MORGAN STANLEY 8-K Report, Corporate Update (Jun 30, 2023)

On June 30, 2023, Morgan Stanley announced two capital-return actions following the Federal Reserve's 2023 stress test results. The quarterly common stock dividend will rise to $0.85 per share from $0.775, a 9.7% increase, beginning with the dividend expected to be declared in the third quarter of 2023. The Board also reauthorized a multi-year common equity share repurchase program of up to $20 billion with no set expiration date, starting in the third quarter. The Federal Reserve set Morgan Stanley's Stress Capital Buffer (SCB) at 5.4% for the period October 1, 2023 through September 30, 2024. Combined with other elements of the regulatory capital framework, this yields an aggregate U.S. Basel III Standardized Approach CET1 ratio requirement of 12.9%. Morgan Stanley's actual CET1 ratio was 15.1% as of March 31, 2023, implying roughly 220 basis points of headroom above the requirement. For investors, the announcement signals management confidence in capital strength and earnings durability, particularly in Wealth and Investment Management. The larger dividend and the buyback renewal return capital directly to shareholders, though repurchases will be executed opportunistically based on market conditions, capital position, and economic outlook. The filing is a forward-looking statement, and actual capital actions depend on future Board decisions.

Jun 30, 2023 8-K

Shareholder Matters

MORGAN STANLEY 8-K Report, Shareholder Vote Results (May 22, 2023)

Morgan Stanley's 8-K filing from May 22, 2023, details the outcomes of its Annual Meeting of Shareholders held on May 19, 2023. The primary focus is on shareholder voting results for several key proposals, including the election of directors, ratification of the independent auditor, executive compensation approval, and shareholder-initiated proposals. Investors will note that all incumbent directors were re-elected with significant support, and the appointment of Deloitte & Touche LLP as the independent auditor for fiscal year 2023 was ratified. The advisory vote to approve the compensation of named executive officers also passed. Importantly, shareholders voted overwhelmingly in favor of holding an advisory vote on executive compensation annually, a decision the Board has committed to for at least the next six years.

May 22, 2023 8-K

Corporate ChangesExhibits & Filings

MORGAN STANLEY 8-K Report, Financial Results (Apr 19, 2023)

Morgan Stanley reported first-quarter 2023 net revenues of $14.5 billion, roughly flat (down 2%) from $14.8 billion a year earlier, while net income applicable to Morgan Stanley fell 19% to $3.0 billion and diluted EPS declined to $1.70 from $2.02. Pre-tax income fell 18% to $3.8 billion, and the expense efficiency ratio worsened to 72% from 69%, reflecting higher non-compensation costs, including litigation, and a sharp rise in provisions for credit losses to $234 million from $57 million, driven by commercial real estate exposure and a weaker macroeconomic outlook. Return on tangible equity was 16.9%, down from 19.8%, though management highlighted the franchise's resilience in a volatile market. The quarter's results were mixed across segments. Institutional Securities revenues declined 11% year over year to $6.8 billion, with Investment Banking down 24% on lower advisory and IPO activity, though Equity and Fixed Income remained relatively strong. Wealth Management was the bright spot, with revenues up 11% to $6.6 billion on higher net interest income, and it attracted $110 billion in net new assets, although fee-based asset flows slowed sharply from the prior year. Investment Management revenues fell 3% to $1.3 billion amid lower asset values and continued net outflows. Capital and shareholder returns remained robust. The standardized CET1 ratio was 15.1%, up from 14.5% a year earlier and 180 basis points above requirements including buffers. The firm repurchased $1.5 billion of stock and declared a quarterly dividend of $0.775 per share. Investors should weigh the solid capital position and wealth management inflows against softer investment banking activity, a substantial increase in credit provisions, and margin compression from higher expenses.

Apr 19, 2023 8-K

MORGAN STANLEY 8-K Report, Bylaw Amendment (Jan 23, 2023)

Morgan Stanley (MS) filed an 8-K on January 23, 2023, to report amendments to its Amended and Restated Bylaws, effective January 20, 2023. These changes are primarily to align with new SEC universal proxy rules (Rule 14a-19) and aim to clarify procedural and disclosure requirements for shareholders proposing director nominations. The amendments also include updates related to quorum and other technical revisions. For investors, the key takeaway is that Morgan Stanley is proactively updating its governance documents to ensure compliance with evolving proxy regulations. This move is expected to enhance transparency and fairness in the director nomination and election process. While these amendments are largely procedural and technical, they reflect the company's commitment to good corporate governance and adapting to regulatory changes.

Jan 23, 2023 8-K

MORGAN STANLEY 8-K Report, Corporate Update (Jan 20, 2023)

Morgan Stanley (MS) filed an 8-K on January 20, 2023, announcing the 2022 compensation for its Chairman and CEO, James P. Gorman. The Compensation Committee recognized Mr. Gorman's leadership in navigating a challenging market, with the firm reporting $53.7 billion in net revenues and $11 billion in net income for 2022, alongside a CET1 ratio of 15.3%. The firm also continued its commitment to shareholder returns through increased dividends and share repurchases. Despite the firm's resilient performance, 2022 results were not as strong as the record-setting prior year. Consequently, Mr. Gorman's total compensation for 2022 was set at $31.5 million, a 10% decrease from $35 million in 2021, reflecting the firm's overall performance. A significant portion of his compensation, 75% of incentive pay, is deferred over three years and delivered in equity awards, with 60% of his bonus in performance-vested equity, aligning his interests with those of shareholders.

Jan 20, 2023 8-K

MORGAN STANLEY 8-K Report, Financial Results (Jan 17, 2023)

Morgan Stanley reported fourth-quarter 2022 net revenues of $12.7 billion (down 12% from $14.5 billion a year earlier), EPS of $1.26 (versus $2.01), and ROTCE of 12.6%. For the full year 2022, net revenues were $53.7 billion (down 10%), net income applicable to Morgan Stanley was $11.0 billion, EPS was $6.15 (versus $8.03), and ROTCE was 15.3% (15.7% excluding integration-related expenses). The decline was concentrated in Institutional Securities, where investment banking revenues fell 49% on weak M&A and equity underwriting volumes. Wealth Management was the bright spot, posting record full-year net revenues of $24.4 billion, a pre-tax margin of 27.0%, and $311 billion of net new assets, though quarterly net new assets slowed sharply to $51.6 billion. Capital and shareholder returns remained strong. The Standardized CET1 ratio was 15.3%, the firm repurchased $9.9 billion of stock during 2022, and the Board declared a $0.775 quarterly dividend. Expenses were a key pressure point: the full-year expense efficiency ratio rose to 73%, compensation fell only modestly, and non-compensation costs rose on technology investment and a $200 million regulatory matter. Quarterly results also included $133 million of severance tied to a December employee action. The accompanying investor presentation, "Driving Growth Through The Next Decade," reframes the story around long-term targets: $1 trillion of net new wealth assets roughly every three years, a 30%+ Wealth Management pre-tax margin, a efficiency ratio below 70%, ROTCE of 20%+, and $10 trillion in client assets. Management argues that these targets are supported by the firm's business mix, which is shifting toward Wealth and Investment Management. These targets are aspirational and assume normal market conditions, so investors should weigh them against the weak 2022 results.

Jan 17, 2023 8-K

Leadership Changes

MORGAN STANLEY 8-K Report, Executive Changes (Jan 9, 2023)

Morgan Stanley has filed an 8-K report to announce the retirement of Jonathan M. Pruzan, Executive Vice President and Chief Operating Officer, effective January 31, 2023. This change in a key executive position is the primary focus of this filing. Investors should note that Mr. Pruzan's departure marks the end of his tenure in a significant operational role within the company. The company has not provided extensive details regarding the succession plan or the reasons for Mr. Pruzan's retirement in this specific filing. However, given the timing, it is important for investors to monitor future communications from Morgan Stanley for updates on leadership transitions and any potential impact on the company's strategic direction and operational execution. This announcement is an important event to track for understanding the ongoing leadership dynamics at Morgan Stanley.

Jan 9, 2023 8-K

Shareholder MattersCorporate ChangesOther Events+1

MORGAN STANLEY 8-K Report, Financial Results (Oct 14, 2022)

Morgan Stanley reported third-quarter 2022 results on October 14, 2022, with net revenues of $13.0 billion, down 12% from $14.8 billion a year earlier, and net income applicable to Morgan Stanley of $2.6 billion, or $1.47 per diluted share, versus $1.98 a year ago. Return on average tangible common equity was 14.6% (15.2% excluding integration-related expenses), and the firm's expense efficiency ratio was 74%. The decline was driven by sharp drops in Investment Banking (down 55% year over year) and Equity revenues (down 14%), reflecting weak global equity volumes and subdued deal activity, partly offset by a 33% increase in Fixed Income revenues on strong macro trading. Wealth Management was the relative bright spot, with revenues up 3% to $6.1 billion, net interest income up 49% on higher rates, and $65 billion of net new assets in the quarter. However, asset-based fee revenue fell 7% as lower market levels reduced client assets, and transactional revenue dropped 18%. Investment Management revenues fell 20% to $1.2 billion, with pre-tax income down 69%, partly due to reversed carried interest in certain private funds, and long-term net outflows persisted at $1.9 billion. Capital and shareholder returns remained solid. The Standardized CET1 ratio was 14.8%, 150 basis points above the updated requirement effective October 1, 2022. Morgan Stanley repurchased $2.6 billion of common stock and declared a quarterly dividend of $0.775 per share, payable November 15, 2022. Tangible book value per share declined to $39.93 from $40.47 a year earlier, a modest but watched metric for investors given the market-driven pressure on earnings.

Oct 14, 2022 8-K

MORGAN STANLEY 8-K Report, Rights Modification (Aug 2, 2022)

Morgan Stanley filed an 8-K report on August 2, 2022, detailing the establishment and issuance of its 6.500% Non-Cumulative Preferred Stock, Series P. This new series of preferred stock carries a liquidation preference of $25,000 per share. The filing indicates that the issuance of this Series P Preferred Stock imposes certain restrictions on Morgan Stanley's ability to declare or pay dividends, or to purchase or redeem, its 'junior stock,' which includes common stock, should the company fail to make full dividend payments on the Series P Preferred Stock.

Aug 2, 2022 8-K

MORGAN STANLEY 8-K Report, Financial Results (Jul 14, 2022)

Morgan Stanley reported second-quarter 2022 results on July 14, 2022, with net revenues of $13.1 billion, down 11% from $14.8 billion a year earlier, and GAAP EPS of $1.39 versus $1.85. Net income applicable to Morgan Stanley fell 29% to $2.5 billion, and the expense efficiency ratio rose to 74% from 69%, which includes a $200 million charge tied to a regulatory matter involving unapproved personal devices and record-keeping. Return on tangible equity was 13.8% (14.3% excluding integration-related expenses), compared with 18.6% a year ago. The quarter reflected a more volatile market: Fixed Income (+49% year over year to $2.5 billion) and Equity (+5% to $3.0 billion) offset a steep decline in Investment Banking (-55% to $1.1 billion). Wealth Management revenue fell 6% to $5.7 billion, held back by mark-to-market losses on employee deferred compensation investments and lower transactional revenue, though net interest income rose 39% to $1.7 billion on higher rates and bank lending. The segment added $52.9 billion of net new assets, and fee-based flows were $28.5 billion. Investment Management revenue fell 17% to $1.4 billion, and long-term net flows turned negative at $(3.5) billion after $13.5 billion a year earlier. From a capital perspective, the Standardized CET1 ratio was 15.2%, 190 basis points above the new aggregate requirement effective October 1, 2022. Morgan Stanley repurchased $2.7 billion of stock, completing a $12 billion program, and announced a new authorization of up to $20 billion with no set expiration. The board also declared a quarterly dividend of $0.775 per share, an 11% increase from $0.70.

Jul 14, 2022 8-K

MORGAN STANLEY 8-K Report, Corporate Update (Jun 27, 2022)

Morgan Stanley (NYSE: MS) announced on June 27, 2022 that it will raise its quarterly common stock dividend by about 11%, from $0.70 to $0.775 per share, beginning with the dividend expected to be declared in the third quarter of 2022. The Board also authorized a new multi-year common equity share repurchase program of up to $20 billion with no set expiration date, starting in the third quarter. Repurchases may be made through open market or privately negotiated transactions, including Rule 10b5-1 plans, and will depend on market conditions, capital position, and the economic and earnings outlook. The capital actions follow the Federal Reserve's CCAR 2022 stress test results, published June 23, 2022. Morgan Stanley will be subject to a Stress Capital Buffer (SCB) of 5.8% from October 1, 2022 through September 30, 2023. Combined with other regulatory capital framework features, this yields an aggregate U.S. Basel III Standardized Approach CET1 ratio of 13.3%, compared with 14.5% as of March 31, 2022. The filing does not disclose the cushion above minimum requirements, so investors should weigh the implied reduction in the CET1 ratio against the size of the new buybacks. management attributes the capital return to durable earnings from the Wealth Management and Investment Management businesses. CEO James P. Gorman noted that the dividend was doubled the prior year and framed the increase as a continuation of a robust capital return program that still leaves room to invest in growth. For investors, the key takeaways are a higher income stream per share, a sizable buyback authorization, and a stress-tested capital position that remains well above regulatory minimums.

Jun 27, 2022 8-K

Shareholder Matters

MORGAN STANLEY 8-K Report, Shareholder Vote Results (May 27, 2022)

Morgan Stanley's 8-K filing dated May 27, 2022, reports the outcomes of its 2022 Annual Meeting of Shareholders held on May 26, 2022. The meeting primarily focused on shareholder votes regarding the election of directors, ratification of the independent auditor, advisory approval of executive compensation, and a shareholder proposal concerning fossil fuel development financing. All director nominees were elected, the appointment of Deloitte & Touche LLP as the auditor was ratified, and the compensation of named executive officers received advisory approval. These outcomes indicate shareholder confidence in the company's governance and management. Notably, a shareholder proposal to cease financing new fossil fuel development was not approved, signaling that the company's current approach to energy sector financing will continue without this specific restriction. This filing provides transparency on key governance matters and shareholder sentiment on critical environmental, social, and governance (ESG) issues.

May 27, 2022 8-K

MORGAN STANLEY 8-K Report, Financial Results (Apr 14, 2022)

Morgan Stanley reported first-quarter 2022 results on April 14, 2022, with net revenues of $14.8 billion, down 6% from $15.7 billion a year earlier, and net income applicable to Morgan Stanley of $3.7 billion, or $2.02 per diluted share, versus $2.19 a year ago. Return on average tangible common equity was 19.8% (versus 21.1%), and the expense efficiency ratio rose to 69% from 67%. Pre-tax income fell 14% year over year to $4.6 billion, as compensation expense declined 8% but non-compensation expenses rose 6%. The quarter's results were supported by Equity trading and Advisory M&A, but offset by weaker Investment Banking underwriting and Transactional revenues in Wealth Management, as well as an outflow-driven decline in Investment Management AUM. Segment performance was mixed. Institutional Securities revenues fell 11% year over year to $7.7 billion, with Investment Banking down 37% on lower equity and fixed income underwriting, partly offset by Advisory revenues that nearly doubled and a 10% rise in Equity revenues. Wealth Management was flat at $5.9 billion, with asset management revenues up 14% and net new assets of $142 billion (including $75 billion from an asset acquisition), while the pre-tax margin was 26.5%. Investment Management revenues were flat at $1.3 billion, but pre-tax income dropped to $228 million from $370 million, and long-term net flows turned negative at $(14.4) billion. Capital and shareholder returns remained strong. The Firm repurchased $2.9 billion of common stock and declared a $0.70 quarterly dividend payable May 13, 2022. The Standardized CET1 ratio was 14.5%, down from 16.7% a year earlier, reflecting higher risk-weighted assets and capital actions. Investors will likely focus on whether revenue pressure from weaker underwriting and volatile markets persists, and on how the firm balances buybacks against a lower capital ratio.

Apr 14, 2022 8-K

MORGAN STANLEY 8-K Report, Corporate Update (Jan 21, 2022)

Morgan Stanley (MS) filed an 8-K on January 21, 2022, detailing the 2021 compensation for its Chairman and CEO, James P. Gorman. The compensation was determined based on Mr. Gorman's strong individual performance and the Firm's record financial achievements in 2021, which met or exceeded stated two-year objectives. This included record revenues, profits, and earnings per share, alongside improvements in key performance metrics like ROTCE and efficiency ratio. The report highlights significant shareholder returns, a substantial increase in market value, and successful integration of recent acquisitions, positioning the Firm for continued growth. Mr. Gorman's total compensation for 2021 was set at $35 million, an increase from the prior year. This compensation package includes a base salary, cash bonus, deferred equity, and a significant performance-vested equity award. A substantial portion of his incentive compensation is deferred and equity-based, aligning his interests with those of shareholders. The performance-vested portion of the award has specific targets tied to return on tangible common equity and relative total shareholder return over a three-year period, with adjusted targets reflecting the Firm's strategic transformation.

Jan 21, 2022 8-K